Transitional cell carcinoma due to chronic UroLume stent irritation
J Paddack1, D E Leocádio, C Samathanam
1Department of Urology, Texas Tech University Health Sciences Center, Lubbock, Texas 79415, USA. deanleocadio@gmail.com
Abstract:
UroLume stents have been used for >15 years to improve the voiding dynamics in patients with benign prostatic hyperplasia and urethral stricture disease. Common complications include stent migration, stricture within the stent, and urothelial hyperplasia, any of which could require stent removal, which itself carries morbidity. We report a case of high-grade urothelial carcinoma associated with chronic UroLume application.
Related Concept Videos
Ureters
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Infection II: Pathophysiology
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
